Brief: Enlivex Announces Issuance Of Two U.S. Patents Covering Methods Of Treating Sepsis With Allocetra
05/05/2022 13:38
May 5 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA :
* ENLIVEX ANNOUNCES ISSUANCE OF TWO U.S. PATENTS COVERING
METHODS
OF TREATING SEPSIS WITH ALLOCETRA
Source text for Eikon: ID:nGNX6kDjgF
Further company coverage: ENLV.TA
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment